Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Felix Zintl Martin Schrappe Martin Stanulla Thomas Klingebiel Felix K Niggli |
| Publication date | February 19, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |